Overview
Progyny
?
Peter Anevski
See more contacts
Offices of Physicians
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Fertility specialist, physician
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Medical and Diagnostic Laboratories
,
Nursing Care Facilities (Skilled Nursing Facilities)
View more , Offices of Dentists , Offices of Other Health Practitioners , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Dentists , Offices of Other Health Practitioners , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Modelled
?
Actual
$1.17 billion
Actual
7.22%
-12.41%
$607
DEC
?
?
NASDAQ:PGNY
Contacts
Get in Touch with 5 Principals* and 257 Contacts
-
Peter AnevskiChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$1.17 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $179 | $189 | $80 |
| Net Investing Cash | $196 | -$201 | -$44 |
| Net Financing Cash | -$310 | -$11 | -$8 |
| Net Change in Cash | $65 | -$23 | $29 |
| Cash at Beginning of Period | $97 | $120 | $91 |
| Cash at End of Period | $162 | $97 | $120 |
| Capital Expenditure | -$5 | -$4 | -$3 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $162 | $97 | $120 |
| Accounts Receivable | $235 | $242 | $240 |
| Inventories | $ | $ | $ |
| Other Current Assets | $75 | $301 | $74 |
| Asset Summary | |||
| Total Current Assets | $473 | $640 | $434 |
| Tangible Fixed Assets | $30 | $28 | $15 |
| Intangible Assets | $1 | $ | $0 |
| Total Assets | $607 | $757 | $543 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $95 | $125 | $109 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $74 | $61 | $50 |
| Liability Summary | |||
| Total Current Liabilities | $169 | $186 | $160 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $185 | $203 | $166 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | $144 | $90 | $28 |
| Equity Summary | |||
| Total Equity | $422 | $553 | $377 |
| Shares Outstanding | 85,310,698 | 96,348,522 | 93,301,156 |